Valuation: Revvity, Inc.

Market Cap 16.86B 14.8B 13.97B 12.74B 23.84B 1,616B 24.01B 167B 64.77B 826B 63.31B 61.94B 2,654B P/E 2026 *
63.7x
P/E 2027 * 50.1x
Enterprise Value 18.85B 16.54B 15.62B 14.23B 26.65B 1,806B 26.84B 187B 72.4B 923B 70.76B 69.23B 2,966B EV / Sales 2026 *
6.61x
EV / Sales 2027 * 6.1x
Free-Float
99.74%
Yield 2026 *
0.19%
Yield 2027 * 0.18%
1 day+2.34%
1 week+4.47%
Current month+19.69%
1 month+22.03%
3 months+49.00%
6 months+717.73%
Current year+717.73%
1 week 123.5
Extreme 123.5
133.35
1 month 104.2
Extreme 104.2
133.35
Current year 83.3
Extreme 83.3
133.35
1 year 83.3
Extreme 83.3
133.35
3 years 83.3
Extreme 83.3
133.35
5 years 83.3
Extreme 83.3
133.35
10 years 83.3
Extreme 83.3
133.35
Manager TitleAgeSince
Chief Executive Officer 61 29/12/2019
Director of Finance/CFO 37 05/09/2022
Chief Tech/Sci/R&D Officer - 30/04/2023
Director TitleAgeSince
Chairman 68 29/12/2019
Director/Board Member 74 06/02/2012
Director/Board Member 72 26/07/2016
Change 5-day change 1-year change 3-year change Capi.($)
+2.34%+4.47% - - 16.86B
-0.50%+3.62%+45.40%+34.57% 250B
+0.32%+5.99%+21.45%-9.21% 158B
+1.42%+3.01%-8.15%+39.36% 143B
-1.70%+1.34%-55.27%-16.87% 63.65B
+0.65%-2.23%+13.17%+22.62% 49.74B
-0.03%+10.43%+40.04%+56.05% 48.71B
+1.56%+0.05%-16.49%-20.14% 47.94B
+0.75%+2.82%+48.62%+61.74% 42.59B
-1.42%+12.68%+194.47%+109.45% 40.77B
Average +0.34%+4.22%+31.47%+30.84% 93.77B
Weighted average by Cap. +0.16%+4.19%+25.89%+25.74%

Financials

2026 *2027 *
Net sales 2.85B 2.5B 2.36B 2.15B 4.03B 273B 4.06B 28.28B 10.96B 140B 10.71B 10.48B 449B 3B 2.64B 2.49B 2.27B 4.25B 288B 4.28B 29.8B 11.54B 147B 11.28B 11.04B 473B
Net income 273M 239M 226M 206M 386M 26.16B 389M 2.71B 1.05B 13.36B 1.02B 1B 42.95B 337M 296M 280M 255M 477M 32.34B 480M 3.35B 1.3B 16.52B 1.27B 1.24B 53.1B
Net Debt 1.99B 1.74B 1.65B 1.5B 2.81B 190B 2.83B 19.69B 7.63B 97.22B 7.45B 7.29B 312B 1.46B 1.28B 1.21B 1.1B 2.06B 140B 2.08B 14.47B 5.6B 71.43B 5.48B 5.36B 230B
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
25/09/26 €131.00 +2.34% 58
24/09/26 €128.00 +3.64% 5
23/09/26 €123.50 -1.95% 0
22/09/26 €125.95 +0.40% 64
21/09/26 €125.45 +0.04% 140
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
151.11USD
Average target price
129.00USD
Spread / Average Target
-14.63%

Quarterly revenue - Rate of surprise